Literature DB >> 1998332

Prenatal screening for hemoglobinopathies. III. Applicability of the health belief model.

P T Rowley1, S Loader, C J Sutera, M Walden, A Kozyra.   

Abstract

A comprehensive prenatal hemoglobinopathy screening program in Rochester, NY, has been described in a preceding paper in this issue of the Journal. A woman identified as a carrier may face three decisions. The first is whether to accept the offer of counseling. The second is whether to have her partner tested. If her partner also tests positive, then the third decision is whether to accept the offer of prenatal diagnosis. This report analyzes factors affecting her decision, with special attention being given to factors invoked by the Health Belief Model. Factors predicting that a patient who we identified as a carrier would come for counseling included the following: patient had no prior knowledge that she is a carrier (P less than .001), a gestational age less than 18 wk (P less than .01), and Caucasian race (P less than .05). For sickle cell trait counselees and beta-thalassamia trait counselees, factors found to predict patient's intent to have partner tested were the following: a greater postcounseling knowledge of the disease (P less than .009), a lesser perceived burden of intervention (P less than .011), and belief that the partner is also a carrier (P less than .008). Also for sickle cell trait counselees and beta-thalassemia trait counselees, factors predicting that the partner actually will be tested were the following: living with the partner (P less than .001), gestational age at identification less than or equal to 18 wk (P less than .001), a lesser perceived burden of intervention (P less than .002), and a greater perceived seriousness of the disease (P less than .05).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1991        PMID: 1998332      PMCID: PMC1682984     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  15 in total

1.  Decision making: whether or not to have prenatal diagnosis and abortion for X-linked conditions.

Authors:  D Beeson; M S Golbus
Journal:  Am J Med Genet       Date:  1985-01

2.  Decision making in Huntington's disease and cystic fibrosis.

Authors:  G Evers-Kiebooms
Journal:  Birth Defects Orig Artic Ser       Date:  1987

3.  Why people use health services.

Authors:  I M Rosenstock
Journal:  Milbank Mem Fund Q       Date:  1966-07

4.  Genetic screening: marvel or menace?

Authors:  P T Rowley
Journal:  Science       Date:  1984-07-13       Impact factor: 47.728

5.  Prenatal screening and pregnant women's attitudes toward the abortion of defective fetuses.

Authors:  R R Faden; A J Chwalow; K Quaid; G A Chase; C Lopes; C O Leonard; N A Holtzman
Journal:  Am J Public Health       Date:  1987-03       Impact factor: 9.308

6.  Factors influencing maternal estimates of genetic risk.

Authors:  E E Ekwo; B F Seals; J O Kim; R A Williamson; J W Hanson
Journal:  Am J Med Genet       Date:  1985-03

7.  Impact of genetic counseling and prenatal diagnosis for Down syndrome and neural tube defects.

Authors:  A Swerts
Journal:  Birth Defects Orig Artic Ser       Date:  1987

8.  Prenatal hemoglobinopathy screening: receptivity of Southeast Asian refugees.

Authors:  P T Rowley; S O Loader; C J Sutera; M Walden
Journal:  Am J Prev Med       Date:  1987 Nov-Dec       Impact factor: 5.043

9.  Genetic counseling of asymptomatic carriers in a primary care setting. The effectiveness of screening and counseling for beta-thalassemia trait.

Authors:  M Lipkin; L Fisher; P T Rowley; S Loader; H P Iker
Journal:  Ann Intern Med       Date:  1986-07       Impact factor: 25.391

10.  Prenatal screening for hemoglobinopathies. II. Evaluation of counseling.

Authors:  S Loader; C J Sutera; M Walden; A Kozyra; P T Rowley
Journal:  Am J Hum Genet       Date:  1991-03       Impact factor: 11.025

View more
  5 in total

1.  Using qualitative and quantitative strategies to evaluate knowledge and perceptions about sickle cell disease and sickle cell trait.

Authors:  Marsha J Treadwell; Lakenya McClough; Elliott Vichinsky
Journal:  J Natl Med Assoc       Date:  2006-05       Impact factor: 1.798

Review 2.  Illness representations, self-regulation, and genetic counseling: a theoretical review.

Authors:  Shoshana Shiloh
Journal:  J Genet Couns       Date:  2006-10       Impact factor: 2.537

3.  A comparison of two approaches to education about carrier testing for cystic fibrosis.

Authors:  K P Leonard; L K Bartholomew; P R Swank; G S Parcel
Journal:  J Genet Couns       Date:  1995-06       Impact factor: 2.537

4.  What Predicts the Use of Genetic Counseling Services After the Birth of a Child with Down Syndrome?

Authors:  Veronica Collins; Jane Halliday; Robert Williamson
Journal:  J Genet Couns       Date:  2003-02       Impact factor: 2.537

5.  Parents' experiences of universal screening for haemoglobin disorders: implications for practice in a new genetics era.

Authors:  Louise Locock; Joe Kai
Journal:  Br J Gen Pract       Date:  2008-03       Impact factor: 5.386

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.